Intellectual Property

Intellectual Propertyhttps://www.jonesday.com/en/rss/practices/intellectual-propertyIntellectual Property - Jones Dayen{7607A181-DC9E-431D-A748-697007B2D694}https://www.jonesday.com/en/insights/2026/04/jones-day-presents-crossborder-trade-secret-litigation-in-the-us-courtsVideoJONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. CourtsTue, 21 Apr 2026 09:30:46 -0500{99749055-54E8-4F59-B1BC-6BF981695B65}https://www.jonesday.com/en/insights/2026/04/isps-off-the-hook-supreme-court-narrows-contributory-copyright-liabilityAlertISPs Off the Hook: Supreme Court Narrows Contributory Copyright LiabilityTue, 21 Apr 2026 00:57:00 -0500{A2539DA7-6ADB-4E20-99E8-B98C7323833D}https://www.jonesday.com/en/news/2026/04/the-best-lawyers-in-japan-2027-recognizes-7-jones-day-lawyers-across-8-practice-areasFirm NewsAwards & RankingsThe Best Lawyers in Japan™ 2027 recognizes 7 Jones Day lawyers across 8 practice areasMon, 20 Apr 2026 08:10:51 -0500{279CCA71-20FA-4D5F-B7BD-E6B7FBF925C3}https://www.jonesday.com/en/insights/2026/04/a-tough-dose-100-tariffs-target-foreignmanufactured-brandname-pharmaceuticalsAlertA Tough Dose: 100% Tariffs Target Foreign-Manufactured Brand-Name PharmaceuticalsWed, 08 Apr 2026 12:43:00 -0500{5B5CD28A-8562-46B6-9F27-57009B4163E2}https://www.jonesday.com/en/news/2026/04/jones-day-international-legal-fellowship-commences-for-2026Firm NewsJones Day International Legal Fellowship commences for 2026Wed, 01 Apr 2026 12:12:02 -0500{494E31F9-0B8B-4B4C-A96E-142DB17CFFD8}https://www.jonesday.com/en/news/2026/04/gurneet-singh-to-serve-as-president-of-south-asian-bar-association-of-northern-californiaFirm NewsInclusionGurneet Singh to serve as President of South Asian Bar Association of Northern CaliforniaWed, 01 Apr 2026 10:30:00 -0500{56DC814C-3680-4BAC-ACBA-4990DF8777A7}https://www.jonesday.com/en/insights/2026/03/white-house-unveils-national-ai-legislative-frameworkAlertWhite House Unveils National AI Legislative FrameworkTue, 31 Mar 2026 09:13:00 -0500{DD58D124-403E-4D1D-953D-E32EF2E4BC3B}https://www.jonesday.com/en/insights/2026/03/washington-state-passes-broad-prohibition-on-noncompete-agreementsAlertWashington State Passes Broad Prohibition on Non-compete AgreementsWed, 25 Mar 2026 04:09:00 -0500{28FD76CC-26CC-4CFE-8C60-728197D9ECD0}https://www.jonesday.com/en/insights/2026/03/unintended-consequences-gao-report-questions-impact-of-exercising-marchin-rights-for-drug-pricingCommentaryUnintended Consequences: GAO Report Questions Impact of Exercising March-In Rights for Drug PricingFri, 20 Mar 2026 04:16:00 -0500{A289D3D4-31FE-4C0F-884E-CBE17457E562}https://www.jonesday.com/en/insights/2026/03/informative-no-discretionary-denial-where-prior-ipr-suggests-material-error-by-office-iptab-litigation-blogiBlogINFORMATIVE: No Discretionary Denial Where Prior IPR Suggests Material Error By Office, PTAB Litigation BlogThu, 19 Mar 2026 08:14:00 -0500{7D7CC519-D782-41BE-AC9A-D7727A63A1B2}https://www.jonesday.com/en/insights/2026/03/jones-day-presents-trade-secret-litigation-10-years-after-enactment-of-the-defend-trade-secrets-actVideoJONES DAY PRESENTS®: Trade Secret Litigation 10 Years After Enactment of the Defend Trade Secrets ActWed, 18 Mar 2026 07:04:27 -0500{CDE4F68D-9FDB-48E7-A589-95FE7D3CF48B}https://www.jonesday.com/en/insights/2026/03/jones-day-talks-women-in-ip--supreme-court-denies-review-of-thaler-v-perlmutter-ai-authorship-questions-remainPodcastJONES DAY TALKS®: Women in IP – Supreme Court Denies Review of Thaler v. Perlmutter: AI Authorship Questions RemainTue, 17 Mar 2026 04:38:00 -0500{3D2F62AB-291B-493B-A451-22AA9CA18854}https://www.jonesday.com/en/insights/2026/03/chief-judge-signals-changes-may-be-coming-for-the-ordinary-observer-test-iptab-litigation-blogiBlogChief Judge Signals Changes May Be Coming for the Ordinary Observer Test, PTAB Litigation BlogFri, 13 Mar 2026 08:23:00 -0500{C5C307D1-70FE-4622-B5CF-EB9946D2B8AE}https://www.jonesday.com/en/insights/2026/03/director-review-emphasizes-singleconstruction-iptab-litigation-blogiBlogDirector Review Emphasizes Single-Construction, PTAB Litigation BlogMon, 02 Mar 2026 04:29:00 -0600{1DCB6630-1DA4-4506-92E5-737B43B73379}https://www.jonesday.com/en/insights/2026/02/precedential-timebarred-copycat-petitions-only-in-exceptional-circumstances-iptab-litigation-blogiBlogPrecedential: Time-Barred Copycat Petitions Only In Exceptional Circumstances, PTAB Litigation BlogTue, 17 Feb 2026 05:59:00 -0600{2110FD1E-9ECC-49BD-803B-8FF4F95A2652}https://www.jonesday.com/en/insights/2026/02/hhs-signals-policy-direction-to-accelerate-adoption-of-ai-in-clinical-careAlertHHS Signals Policy Direction to Accelerate Adoption of AI in Clinical CareMon, 09 Feb 2026 08:34:00 -0600{3BFC2955-5BC5-49E0-9E7F-7535A51288D4}https://www.jonesday.com/en/insights/2026/02/claim-construction-stipulation-avoids-discretionary-denialBlogClaim Construction Stipulation Avoids Discretionary Denial, PTAB Litigation BlogMon, 09 Feb 2026 05:16:00 -0600{8D6ECD93-E12B-4F9E-A7AB-414C898AECD5}https://www.jonesday.com/en/news/2026/02/twelve-jones-day-lawyers-named-to-lawdragons-2026-500-leading-global-antitrust--competition-lawyers-listAwards & RankingsTwelve Jones Day lawyers named to Lawdragon’s 2026 "500 Leading Global Antitrust & Competition Lawyers" listFri, 06 Feb 2026 08:19:15 -0600{021BAA68-F220-4940-850B-14E2DD5C341D}https://www.jonesday.com/en/insights/2026/02/newsletter-vital-signs-digital-health-law-update--winter-2026NewslettersVital Signs: Digital Health Law Update | Winter 2026Thu, 05 Feb 2026 09:05:00 -0600{92024C9A-2BB2-462D-89FF-177F891074AB}https://www.jonesday.com/en/news/2026/02/jones-day-and-partner-randy-kay-ranked-outstanding-on-world-ip-reviews-usa-trade-secrets-2025-listAwards & RankingsJones Day and partner Randy Kay ranked Outstanding on World IP Review's USA Trade Secrets 2025 listWed, 04 Feb 2026 07:50:14 -0600{C5EF66DB-F8CD-4774-AD36-ECACF4A911BB}https://www.jonesday.com/en/news/2026/02/world-trademark-review-ranks-jones-days-trademark-practice-in-2026-wtr-1000Awards & RankingsWorld Trademark Review ranks Jones Day's trademark practice in 2026 WTR 1000Mon, 02 Feb 2026 03:58:12 -0600{553B527C-E2F4-4958-B11F-FFC81D5F851D}https://www.jonesday.com/en/insights/2026/01/global-trade-secret-update-key-developments-in-2025White PaperYear in ReviewGlobal Trade Secret Update: Key Developments in 2025Thu, 29 Jan 2026 11:24:00 -0600{A4C1ED6E-6DC4-4971-8723-29238FE6F031}https://www.jonesday.com/en/insights/2026/01/ema-and-fda-align-on-good-ai-practice-in-drug-developmentAlertEMA and FDA Align on Good AI Practice in Drug DevelopmentWed, 28 Jan 2026 05:40:43 -0600{8F599290-9A57-40E6-898F-3A85574DA612}https://www.jonesday.com/en/insights/2026/01/european-commission-publishes-draft-code-of-practice-on-ai-labelling-and-transparencyCommentaryEuropean Commission Publishes Draft Code of Practice on AI Labelling and TransparencyTue, 27 Jan 2026 07:17:00 -0600{7C0A1B18-1AFD-4D88-B05C-28D1DE942FDD}https://www.jonesday.com/en/insights/2026/01/a-relaxing-2026-fda-updates-general-wellness-and-clinical-decision-support-software-guidanceAlertA Relaxing 2026? FDA Updates General Wellness and Clinical Decision Support Software GuidanceThu, 22 Jan 2026 00:00:00 -0600{8B39782C-732D-44D5-9835-D8847C24DCAD}https://www.jonesday.com/en/insights/2026/01/ptab-statistics-through-two-months-of-fy-2026BlogPTAB Statistics Through Two Months of FY 2026, PTAB Litigation BlogFri, 16 Jan 2026 00:00:00 -0600{70F6F50E-2E09-4D86-BED8-B27979842920}https://www.jonesday.com/en/insights/2026/01/federal-circuit-holds-ipr-estoppel-inapplicable-to-ongoing-eprsBlogFederal Circuit Holds IPR Estoppel Inapplicable to Ongoing EPRs, PTAB Litigation BlogThu, 08 Jan 2026 00:00:00 -0600{DB97579A-1683-418C-997D-1C3ED2C10540}https://www.jonesday.com/en/insights/2025/12/copyright-in-applied-art-cjeu-sets-a-clearer-stricter-testCommentaryCopyright in Applied Art: CJEU Sets a Clearer, Stricter TestWed, 31 Dec 2025 00:00:00 -0600{6362F313-06EB-4968-8AC9-F9646FAA02B1}https://www.jonesday.com/en/insights/2025/12/ptab-voluntary-search-disclosure-declarations-a-new-factor-supporting-institutionBlogPTAB Voluntary Search Disclosure Declarations: A New Factor Supporting Institution, PTAB Litigation BlogWed, 24 Dec 2025 00:00:00 -0600{A28EA763-002C-401F-953A-7A26165D4E4D}https://www.jonesday.com/en/insights/2025/12/upc-aligns-with-the-epo-in-allowing-functional-antibody-claimsCommentaryUPC Aligns With the EPO in Allowing Functional Antibody ClaimsTue, 23 Dec 2025 00:00:00 -0600{91D99DDC-1090-4345-A668-79CB33B26C8A}https://www.jonesday.com/en/insights/2025/12/prosecution-error-evidence--timing-considerations-sends-ipr-forwardBlogProsecution Error Evidence & Timing Considerations Sends IPR Forward, PTAB Litigation BlogMon, 22 Dec 2025 00:00:00 -0600{A655B61A-0A94-4B08-8EA5-73E9CCE83641}https://www.jonesday.com/en/insights/2025/12/from-fragmented-to-framework-executive-order-advances-national-ai-consistencyAlertFrom Fragmented to Framework: Executive Order Advances National AI ConsistencyFri, 19 Dec 2025 00:00:00 -0600{2FCD78F1-703A-412B-BD07-8B133030FD1A}https://www.jonesday.com/en/insights/2025/12/the-eu-pharma-package-is-a-done-deal-a-holiday-gift-or-notCommentaryThe EU Pharma Package Is a Done Deal: a Holiday Gift, or Not?Thu, 18 Dec 2025 00:00:00 -0600{52304A15-D488-44A8-968A-61F43A9D6DCD}https://www.jonesday.com/en/news/2025/12/jones-day-lawyers-and-practices-earn-top-rankings-in-chambers-asiapacific-2026Awards & RankingsFirm NewsJones Day Lawyers and Practices Earn Top Rankings in Chambers Asia-Pacific 2026Fri, 12 Dec 2025 00:00:00 -0600{ECE06F87-3BBD-4959-89F8-1A25CDD49080}https://www.jonesday.com/en/insights/2025/12/innovative-insights-legal-updates-in-life-sciences-fourth-quarter-2025NewslettersInnovative Insights: Legal Updates in Life Sciences | Fourth Quarter 2025Thu, 11 Dec 2025 00:00:00 -0600{DD4B8EE6-494C-45A8-84C0-F6D1D3FF4804}https://www.jonesday.com/en/insights/2025/12/uspto-director-institution-decisions-back-to-the-futureBlogUSPTO Director Institution Decisions: Back To The Future?, PTAB Litigation BlogWed, 10 Dec 2025 00:00:00 -0600{DCA15ADC-C362-4885-A190-D8B04578FBEA}https://www.jonesday.com/en/insights/2025/12/uspto-revises-guidance-on-aiassisted-inventorshipAlertUSPTO Revises Guidance on AI-Assisted InventorshipFri, 05 Dec 2025 00:00:00 -0600{B4A9250E-1666-419F-A80E-13101E017F69}https://www.jonesday.com/en/insights/2025/12/balancing-possibilities-with-realitiescyber-and-privacy-legal-trends-in-life-sciencesNewslettersBalancing Possibilities with Realities—Cyber and Privacy Legal Trends in Life SciencesThu, 04 Dec 2025 00:00:00 -0600{C0C58793-4722-429D-8420-3DFA772E9FFF}https://www.jonesday.com/en/insights/2025/12/commissioners-national-priority-voucher-program-and-coverage-considerationsNewslettersCommissioner's National Priority Voucher Program and Coverage ConsiderationsThu, 04 Dec 2025 00:00:00 -0600{D9AF84B7-A5A7-4069-BD01-4BD8E79F3010}https://www.jonesday.com/en/insights/2025/12/fdas-support-for-onshoring-drug-manufacturing-and-increasing-oversight-of-foreign-facilitiesNewslettersFDA's Support for Onshoring Drug Manufacturing and Increasing Oversight of Foreign FacilitiesThu, 04 Dec 2025 00:00:00 -0600{4575EFC6-1E68-40AF-A578-3C1B24F4CA4E}https://www.jonesday.com/en/insights/2025/12/most-favored-nation-drug-pricing-and-manufacturer-agreementsNewslettersMost Favored Nation Drug Pricing and Manufacturer AgreementsThu, 04 Dec 2025 00:00:00 -0600{EF4E81FA-0946-48BE-AF75-14FAEF8F5C9C}https://www.jonesday.com/en/insights/2025/12/the-current-legal-landscape-of-the-340b-drug-pricing-programNewslettersThe Current Legal Landscape of the 340B Drug Pricing ProgramThu, 04 Dec 2025 00:00:00 -0600{4CABFCF8-DC8D-4170-B88A-A51D309B3A40}https://www.jonesday.com/en/insights/2025/12/trump-administration-updates-for-the-life-sciences-industry--q4-editionNewslettersTrump Administration Updates for the Life Sciences Industry Q4 Edition Thu, 04 Dec 2025 00:00:00 -0600{1E7D351D-7087-473D-9590-13E79DFF8F22}https://www.jonesday.com/en/insights/2025/12/fda-biosimilar-playbook-merging-biosimilarity-with-interchangeabilityCommentaryFDA's Biosimilar Playbook: Merging Biosimilarity with InterchangeabilityWed, 03 Dec 2025 00:00:00 -0600{C3E73A30-6AA4-4D0D-8FF4-1EEC8659CA0C}https://www.jonesday.com/en/insights/2025/11/precedential-ptab-clarifies-real-party-in-interest-analysisBlogPRECEDENTIAL: PTAB Clarifies Real Party in Interest Analysis, PTAB Litigation BlogWed, 26 Nov 2025 00:00:00 -0600{12E38887-5572-4CD0-B9B0-BE13008EB8C8}https://www.jonesday.com/en/insights/2025/11/japanese-government-considers-potential-improvements-to-patent-linkage-system-for-genericsCommentaryJapanese Government Considers Potential Improvements to Patent Linkage System for GenericsTue, 25 Nov 2025 00:00:00 -0600{1EBDC5BD-953A-4916-848F-DE5093D61ED3}https://www.jonesday.com/en/insights/2025/11/collateral-estoppel-may-not-apply-when-claim-interpretation-standards-differBlogCollateral Estoppel May Not Apply When Claim Interpretation Standards Differ, PTAB Litigation BlogThu, 20 Nov 2025 00:00:00 -0600{42E66ED3-F252-4E09-A915-786502C18812}https://www.jonesday.com/en/insights/2025/11/proposed-rulemaking-aims-to-change-access-to-ipr-proceedingsBlogProposed Rulemaking Aims to Change Access to IPR Proceedings, PTAB Litigation BlogMon, 17 Nov 2025 00:00:00 -0600{5C53FDCC-2C1D-44AB-8A39-403523AE32B6}https://www.jonesday.com/en/insights/2025/08/uk-court-of-appeal-upholds-invalidation-of-adidas-three-stripe-position-marksAlertUK Court of Appeal Upholds Invalidation of Adidas' "Three Stripe" Position MarksFri, 07 Nov 2025 00:00:00 -0600{F9A0A0D6-5A66-4FD5-86D0-F6CA22159620}https://www.jonesday.com/en/news/2025/11/jones-day-named-law-firm-of-the-year-in-appellate-practice-among-293-rankings-in-the-2026-edition-of-best-law-firmsAwards & RankingsFirm NewsJones Day named "Law Firm of the Year" in Appellate Practice among 293 rankings in the 2026 edition of Best Law Firms®Thu, 06 Nov 2025 00:00:00 -0600{4A9084CA-1DF7-4298-AA42-EB7185F099E3}https://www.jonesday.com/en/insights/2025/11/discretionary-decision-statistics-updateBlogDiscretionary Decision Statistics Update, PTAB Litigation BlogWed, 05 Nov 2025 00:00:00 -0600{6E0CFEB9-8DCB-4D5D-A57D-BBB9D58DADC8}https://www.jonesday.com/en/insights/2025/11/fda-proposes-removing-comparative-efficacy-studies-for-biosimilarsAlertFDA Proposes to Remove Comparative Efficacy Studies to Accelerate Biosimilar DevelopmentTue, 04 Nov 2025 00:00:00 -0600{58AFD4BD-F353-40A5-8A72-EBA3DEF2E932}https://www.jonesday.com/en/insights/2025/11/ptab-issues-first-summary-institution-denial-decisionsBlogPTAB Issues First Summary Institution (Denial) Decisions, PTAB Litigation BlogMon, 03 Nov 2025 00:00:00 -0600{E810F68F-D106-414A-B174-C541B6615CCC}https://www.jonesday.com/en/insights/2025/10/ptab-presentation-regarding-director-institutionBlogPTAB Presentation Regarding Director Institution, PTAB Litigation BlogFri, 31 Oct 2025 00:00:00 -0500{77EB72DE-5EF3-4829-B16B-ABDFE668C43D}https://www.jonesday.com/en/insights/2025/10/divergent-claim-construction-results-in-discretionary-denialBlogDivergent Claim Construction Results in Discretionary Denial, PTAB Litigation BlogWed, 29 Oct 2025 00:00:00 -0500{74A21702-2C0C-4BEC-A4FA-E72DA8BFE5B1}https://www.jonesday.com/en/insights/2025/10/california-enacts-sb-53-setting-new-standards-for-frontier-ai-safety-disclosuresAlertCalifornia Enacts SB 53, Setting New Standards for Frontier AI Safety DisclosuresFri, 24 Oct 2025 00:00:00 -0500{D8D903B5-0498-4982-9510-6B79D0226A47}https://www.jonesday.com/en/news/2025/10/jones-days-jocelyn-yu-and-nicholas-hodges-named-leaders-of-influence-in-law-by-san-diego-business-journalAwards & RankingsFirm NewsInclusionJones Day’s Jocelyn Yu and Nicholas Hodges named “Leaders of Influence in Law” by San Diego Business JournalThu, 23 Oct 2025 00:00:00 -0500{9DC47119-2D84-4E4E-8BF4-D8CBDCB03074}https://www.jonesday.com/en/insights/2025/10/settled-expectations-insufficient-to-prevent-ipr-reviewBlogSettled Expectations Insufficient To Prevent IPR Review, PTAB Litigation BlogThu, 23 Oct 2025 00:00:00 -0500{E9A38875-9D59-4CB8-974B-F6591BB23E28}https://www.jonesday.com/en/insights/2025/10/director-takes-on-all-institution-dutiesBlogDirector Takes On All Institution Duties, PTAB Litigation BlogMon, 20 Oct 2025 00:00:00 -0500{7A57255D-F990-4CD4-AAAC-9CBB6A2E90DE}https://www.jonesday.com/en/insights/2025/10/ptab-issues-notice-of-discretionary-denial-rulemakingBlogPTAB Issues Notice of Discretionary Denial Rulemaking, PTAB Litigation BlogFri, 17 Oct 2025 00:00:00 -0500{72872530-064B-4111-8EC4-4C29EB906C74}https://www.jonesday.com/en/insights/2025/10/uspto-memorandum-clarifies-ptabs-treatment-of-prior-proceedingsBlogUSPTO Memorandum Clarifies PTAB’s Treatment of Prior Proceedings, PTAB Litigation BlogThu, 16 Oct 2025 00:00:00 -0500{0E52DC3A-1C05-40F0-9649-F05606A830AD}https://www.jonesday.com/en/insights/2025/10/discretionary-denial-statisticsBlogDiscretionary Denial Statistics, PTAB Litigation BlogWed, 15 Oct 2025 00:00:00 -0500{F865409A-E05D-473E-8ED6-36B328009D57}https://www.jonesday.com/en/insights/2025/10/show-me-the-evidence-primary-references-still-required-after-lkqBlogShow Me the Evidence: Primary References Still Required after LKQ, PTAB Litigation BlogThu, 09 Oct 2025 00:00:00 -0500{5A38700F-0D53-47CD-A76A-07718A9ABE22}https://www.jonesday.com/en/insights/2025/10/germany-implements-new-kritis-umbrella-law-and-nis2-directiveAlertStrengthening Critical Infrastructure: Germany's New KRITIS Umbrella Law and NIS-2 ImplementationWed, 08 Oct 2025 00:00:00 -0500{7CCF20DB-783C-4279-8DE8-E3BCD7960467}https://www.jonesday.com/en/news/2025/10/the-best-lawyers-in-germany-2026Firm NewsAwards & RankingsThe Best Lawyers in Germany™ 2026 recognizes 55 Jones Day lawyers across 29 practice areasTue, 07 Oct 2025 00:00:00 -0500{39F028BC-850C-4D5E-97B8-D5376FDC5885}https://www.jonesday.com/en/news/2025/10/jones-day-earns-top-rankings-in-legal-500-united-states-2025Firm NewsAwards & RankingsJones Day earns top rankings in Legal 500 United States 2025Thu, 02 Oct 2025 00:00:00 -0500{DFC3FD42-0BE0-4974-8FAB-C219271958C4}https://www.jonesday.com/en/insights/2025/10/federal-circuit-clarifies-limits-on-patentability-of-clinical-study-resultsbased-applicationsCommentaryFederal Circuit Clarifies Limits on Patentability of Clinical Study Results-Based ApplicationsWed, 01 Oct 2025 00:00:00 -0500{D9493421-D46D-4266-A4EA-0A13D5E981C1}https://www.jonesday.com/en/insights/2025/09/innovative-insights-legal-updates-in-life-sciences--third-quarter-2025NewslettersInnovative Insights: Legal Updates in Life Sciences | Third Quarter 2025Fri, 26 Sep 2025 00:00:00 -0500{B39E024E-7979-4A34-8902-5C1EF912CF78}https://www.jonesday.com/en/insights/2025/09/federal-circuit-clarifies-independent-conception-standard-for-aia-derivationBlogFederal Circuit Clarifies Independent Conception Standard for AIA Derivation, PTAB Litigation BlogThu, 25 Sep 2025 00:00:00 -0500{36E4031B-C244-4CA4-9BA2-5F500609CD92}https://www.jonesday.com/en/insights/2025/09/cjeu-bars-national-inactivity-defenses-beyond-eu-acquiescence-rulesCommentaryTrademark Enforcement Strengthened: CJEU Bars National Inactivity Defenses Beyond EU Acquiescence RulesFri, 19 Sep 2025 00:00:00 -0500{E764C0D7-B0B3-462E-A41F-F612BF0408E3}https://www.jonesday.com/en/insights/2025/09/california-bill-will-require-disclosures-about-data-used-in-training-ai-modelsAlertCalifornia Bill Will Require Disclosures About Data Used in Training AI ModelsWed, 17 Sep 2025 00:00:00 -0500{AEB2C751-93CD-45D0-88C2-193B61769C36}https://www.jonesday.com/en/news/2025/09/jones-days-vishal-khatri-and-carl-kukkonen-named-leading-intellectual-property-lawyers-by-iamAwards & RankingsFirm NewsJones Day's Vishal Khatri and Carl Kukkonen named leading intellectual property lawyers by IAMWed, 17 Sep 2025 00:00:00 -0500{048C9E85-6656-47BD-8F34-281A54C77AF5}https://www.jonesday.com/en/insights/2025/09/postfiling-activity-may-create-privity-leading-to-section-315b-dismissalBlogPost-filing Activity May Create Privity Leading To Section 315(b) Dismissal, PTAB Litigation BlogWed, 17 Sep 2025 00:00:00 -0500{DD11FC2B-BADE-4FFF-9C7D-513E81EF9CD3}https://www.jonesday.com/en/insights/2025/09/a-return-to-traditional-ma--insights-from-first-merger-challenge-of--trump-administrations-federal-trade-commissionNewslettersA Return to Traditional M&A? Insights from First Merger Challenge of Trump Administration’s Federal Trade CommissionFri, 12 Sep 2025 00:00:00 -0500{E3596757-416B-49B0-A421-503A7A5A63C2}https://www.jonesday.com/en/insights/2025/09/filing-litigation-to-challenge-fda-delays-in-nda-or-bla-reviewNewslettersFiling Litigation to Challenge FDA Delays in NDA or BLA ReviewFri, 12 Sep 2025 00:00:00 -0500{B1851733-1505-424C-ACA2-165A198D9C5F}https://www.jonesday.com/en/insights/2025/09/preparing-for-pharmaceutical-tariffs-what-industry-can-do-to-mitigate-supply-chain-risksNewslettersPreparing for Pharmaceutical Tariffs: What Industry Can Do To Mitigate Supply Chain RisksFri, 12 Sep 2025 00:00:00 -0500{6C7DDD89-64B8-49F8-B972-E510FFC0D7D5}https://www.jonesday.com/en/insights/2025/09/skechers-ipr-still-kicking-after-director-reviewBlogSkechers IPR Still Kicking After Director Review, PTAB Litigation BlogFri, 12 Sep 2025 00:00:00 -0500{813AF28E-6FD3-412D-A5FD-F75AE435394B}https://www.jonesday.com/en/insights/2025/09/the-future-is-femtech-innovation-and-investment-in-womens-healthNewslettersThe Future is FemTech: Innovation and Investment in Women’s Health Fri, 12 Sep 2025 00:00:00 -0500{B00EA4DB-7B3C-4AB8-B422-9CB204195214}https://www.jonesday.com/en/insights/2025/09/trump-administration-updates-for-the-health-industryNewslettersTrump Administration Updates for the Health IndustryFri, 12 Sep 2025 00:00:00 -0500{4538DC24-A4E9-4701-85FF-7DAA14D0038F}https://www.jonesday.com/en/insights/2025/09/navigating-the-new-discretionary-denial-bifurcated-frameworkBlogNavigating the New Discretionary Denial Bifurcated Framework, PTAB Litigation BlogThu, 11 Sep 2025 00:00:00 -0500{04D9F1A1-F0A1-4242-8710-806FF6B808A8}https://www.jonesday.com/en/insights/2025/09/skechers-ipr-still-kicking-after-director-reviewBlogSkechers IPR Still Kicking After Director Review, PTAB Litigation BlogThu, 11 Sep 2025 00:00:00 -0500{54B6607A-F712-49D1-A7F9-0E1A1F716A76}https://www.jonesday.com/en/insights/2025/09/acting-director-reverses-previous-discretionary-denialBlogActing Director Reverses Previous Discretionary Denial, PTAB Litigation BlogWed, 03 Sep 2025 00:00:00 -0500{E934B346-AF81-4911-AE7E-D3B79F486B98}https://www.jonesday.com/en/insights/2025/09/japanese-court-shatters-previous-record-for-damages-award-in-a-patent-infringement-caseAlertJapanese Court Shatters Previous Record for Damages Award in a Patent Infringement CaseWed, 03 Sep 2025 00:00:00 -0500{775CFF89-363E-4B1E-9E47-DAD1FD3082B7}https://www.jonesday.com/en/insights/2025/08/institution-denied-based-on-parallel-proceeding-and-prior-denialBlogInstitution Denied Based on Parallel Proceeding and Prior Denial, PTAB Litigation BlogFri, 29 Aug 2025 00:00:00 -0500{6982338E-7D42-4840-B1AE-909F150F9940}https://www.jonesday.com/en/insights/2025/08/bill-seeks-to-restrict-30month-stay-in-hatchwaxman-litigation-to-one-patentAlertBill Seeks to Restrict 30-Month Stay in Hatch-Waxman Litigation to One PatentWed, 27 Aug 2025 00:00:00 -0500{B2F32FAD-F8BA-4279-BEAD-109D0A547301}https://www.jonesday.com/en/insights/2025/08/severed-knowledge-negative-trade-secrets-through-the-lens-of-compartmentalized-memoryCommentarySevered Knowledge: Negative Trade Secrets Through the Lens of Compartmentalized MemoryMon, 25 Aug 2025 00:00:00 -0500{8FB651C1-A6B5-4309-A88F-38921197BBD7}https://www.jonesday.com/en/news/2025/08/the-best-lawyers-in-america-2026-names-400-jones-day-lawyers-across-71-practice-areasAwards & RankingsFirm NewsThe Best Lawyers in America® 2026 names 400 Jones Day lawyers across 71 practice areasThu, 21 Aug 2025 00:00:00 -0500{1CAE4447-7727-463B-8C11-2E494B2F7FC7}https://www.jonesday.com/en/insights/2025/08/cancellation-of-claims-deemed-an-inappropriate-sanctionBlogCancellation of Claims Deemed An Inappropriate Sanction, PTAB Litigation BlogFri, 15 Aug 2025 00:00:00 -0500{93CFA23A-A55D-43F4-95BC-E01152EE93CE}https://www.jonesday.com/en/insights/2025/08/european-parliaments-new-study-on-generative-ai-and-copyright-calls-for-overhaul-of-optout-regimeEuropean Parliament's New Study on Generative AI and Copyright Calls for Overhaul of Opt-Out RegimeWed, 13 Aug 2025 00:00:00 -0500{D20D1DAA-1523-4275-97D2-6212C9E340E2}https://www.jonesday.com/en/insights/2025/08/two-week-deadline-for-ptab-to-issue-notice-of-filing-date-accordedBlogTwo Week Deadline for PTAB to Issue Notice of Filing Date Accorded, PTAB Litigation BlogWed, 13 Aug 2025 00:00:00 -0500{733FB2EF-BC7D-46A2-A4F8-DD057B62E5CA}https://www.jonesday.com/en/insights/2025/08/subsequent-challenge-does-not-justify-discretionary-denialBlogSubsequent Challenge Does Not Justify Discretionary Denial, PTAB Litigation BlogFri, 08 Aug 2025 00:00:00 -0500{A79A1E40-6007-42D3-BAB1-FD96F133E448}https://www.jonesday.com/en/insights/2025/08/acting-director-clarifies-multipetition-policy-for-competing-constructionsBlogActing Director Clarifies Multi-Petition Policy for Competing Constructions, PTAB Litigation BlogWed, 06 Aug 2025 00:00:00 -0500{2A9F957F-CEF2-44DC-B8A9-DCCC9732A921}https://www.jonesday.com/en/insights/2025/08/eu-ai-act-european-commission-publishes-generalpurpose-ai-code-of-practiceCommentaryEU AI Act: European Commission Publishes General-Purpose AI Code of PracticeWed, 06 Aug 2025 00:00:00 -0500{B2912F30-D257-41CD-9F3C-75EA6A610F93}https://www.jonesday.com/en/insights/2025/08/another-fenderbender-between-lkq-and-gmBlogAnother Fender-Bender between LKQ and GM, PTAB Litigation BlogTue, 05 Aug 2025 00:00:00 -0500{882AC652-2F87-4496-A604-0552CDCF2AE9}https://www.jonesday.com/en/insights/2025/08/white-house-issues-executive-orders-on-ai-action-planCommentaryWhite House Issues Executive Orders on AI Action PlanTue, 05 Aug 2025 00:00:00 -0500{E6C72824-0777-463D-B1E2-F8C3734A87EA}https://www.jonesday.com/en/insights/2025/08/with-new-action-plan-white-house-launches-ai-space-racewhat-banks-should-knowAlertWith New Action Plan, White House Launches AI "Space Race"—What Banks Should KnowMon, 04 Aug 2025 00:00:00 -0500{BA58B34B-D930-4425-993F-78313F8379F2}https://www.jonesday.com/en/insights/2025/07/inventor-testimony-of-reduction-date-leads-to-denialBlogInventor Testimony of Reduction Date Leads to Denial, PTAB Litigation BlogTue, 29 Jul 2025 00:00:00 -0500{A9FC8469-D0DC-480D-99B1-D43C0C8653B2}https://www.jonesday.com/en/news/2025/07/jones-days-jennifer-bennett-karen-hewitt-named-top-women-lawyers-by-the-daily-journalAwards & RankingsFirm NewsInclusionJones Day's Jennifer Bennett, Karen Hewitt named "Top Women Lawyers" by the Daily JournalTue, 29 Jul 2025 00:00:00 -0500{D7A94BB1-E500-4A1B-B67B-F27E46A687C4}https://www.jonesday.com/en/insights/2025/07/congress-expands-orphan-drug-exemptions-from-medicare-price-negotiationsAlertCongress Expands Orphan Drug Exemptions From Medicare Price NegotiationsMon, 28 Jul 2025 00:00:00 -0500{F0557D45-C606-48E4-AF27-2450D1746A1E}https://www.jonesday.com/en/insights/2025/07/settledexpectations-analysis-may-leave-some-petitioners-feeling-unsettledBlog“Settled-Expectations” Analysis May Leave Some Petitioners Feeling Unsettled, PTAB Litigation BlogWed, 23 Jul 2025 00:00:00 -0500